TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs987052
log Bayes Factor = <0.0001
Chromosome 16   position 86,322,459  (GRCh37) Explore rs987052 on Ensembl!
Variant rs987052 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C83.3 Large cell (diffuse)
0.053 0.947 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.053 0.947 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.053 0.947 0.000
C81 Hodgkin's disease
0.052 0.948 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.051 0.949 0.000
C81.1 Nodular sclerosis
0.050 0.950 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.047 0.953 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.046 0.954 0.000
C81.9 Hodgkin's disease, unspecified
0.046 0.954 0.000
C82.3 Follicular lymphoma grade IIIa
0.045 0.955 0.000
C82.4 Follicular lymphoma grade IIIb
0.045 0.955 0.000
C82.2 Large cell, follicular
0.043 0.957 0.000
C95 Leukaemia of unspecified cell type
0.042 0.958 0.000
C82.0 Small cleaved cell, follicular
0.041 0.959 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.041 0.959 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.040 0.960 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.039 0.961 0.000
C88 Malignant immunoproliferative diseases
0.038 0.961 0.000
C82.6 Cutaneous follicle centre lymphoma
0.038 0.962 0.000
C82.5 Diffuse follicle centre lymphoma
0.038 0.962 0.000
C83.7 Burkitt's tumour
0.038 0.962 0.000
C83.6 Undifferentiated (diffuse)
0.038 0.962 0.000
C83.5 Lymphoblastic (diffuse)
0.038 0.962 0.000
C83.4 Immunoblastic (diffuse)
0.038 0.962 0.000
C83.2 Mixed small and large cell (diffuse)
0.038 0.962 0.000
C81.0 Lymphocytic predominance
0.037 0.963 0.000
C81.7 Other Hodgkin's disease
0.037 0.963 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.037 0.963 0.000
C81.3 Lymphocytic depletion
0.037 0.963 0.000
C81.2 Mixed cellularity
0.037 0.963 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.037 0.963 0.000
C94 Other leukaemias of specified cell type
0.037 0.963 0.000
C93 Monocytic leukaemia
0.037 0.963 0.000
C86 Other specified types of T/NK-cell lymphoma
0.037 0.963 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.037 0.963 0.000
C95.9 Leukaemia, unspecified
0.035 0.965 0.000
C83.0 Small cell (diffuse)
0.034 0.966 0.000
C83.1 Small cleaved cell (diffuse)
0.034 0.966 0.000
C92 Myeloid leukaemia
0.033 0.967 0.000
C95.7 Other leukaemia of unspecified cell type
0.030 0.970 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.030 0.970 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.030 0.970 0.000
C95.0 Acute leukaemia of unspecified cell type
0.030 0.970 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.029 0.971 0.000
C92.1 Chronic myeloid leukaemia
0.029 0.971 0.000
C91 Lymphoid leukaemia
0.028 0.972 0.000
C84.4 Peripheral T-cell lymphoma
0.028 0.972 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.028 0.972 0.000
C88.7 Other malignant immunoproliferative diseases
0.028 0.972 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.028 0.972 0.000
C88.3 Immunoproliferative small intestinal disease
0.028 0.972 0.000
C88.2 Gamma heavy chain disease
0.028 0.972 0.000
C88.1 Alpha heavy chain disease
0.028 0.972 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.027 0.973 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.027 0.973 0.000
C86.4 Blastic NK-cell lymphoma
0.027 0.973 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.027 0.973 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.027 0.973 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.027 0.973 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.027 0.973 0.000
C93.9 Monocytic leukaemia, unspecified
0.027 0.973 0.000
C93.7 Other monocytic leukaemia
0.027 0.973 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.027 0.973 0.000
C93.2 Subacute monocytic leukaemia
0.027 0.973 0.000
C93.1 Chronic monocytic leukaemia
0.027 0.973 0.000
C93.0 Acute monocytic leukaemia
0.027 0.973 0.000
C94.7 Other specified leukaemias
0.027 0.973 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.027 0.973 0.000
C94.5 Acute myelofibrosis
0.027 0.973 0.000
C94.4 Acute panmyelosis
0.027 0.973 0.000
C94.3 Mast cell leukaemia
0.027 0.973 0.000
C94.2 Acute megakaryoblastic leukaemia
0.027 0.973 0.000
C94.1 Chronic erythraemia
0.027 0.973 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.027 0.973 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.027 0.973 0.000
C96.8 Histiocytic sarcoma
0.027 0.973 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.027 0.973 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.027 0.973 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.027 0.973 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.027 0.973 0.000
C96.3 True histiocytic lymphoma
0.027 0.973 0.000
C96.2 Malignant mast cell tumour
0.027 0.973 0.000
C96.1 Malignant histiocytosis
0.027 0.973 0.000
C96.0 Letterer-Siwe disease
0.027 0.973 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.027 0.973 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.027 0.973 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.027 0.973 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.027 0.973 0.000
C84.3 Lymphoepithelioid lymphoma
0.027 0.973 0.000
C84.2 T-zone lymphoma
0.027 0.973 0.000
C84.1 Sezary's diease
0.027 0.973 0.000
C84.0 Mycosis fungoides
0.026 0.974 0.000
C84.5 Other and unspecified T-cell lymphomas
0.026 0.974 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.024 0.975 0.000
C92.9 Myeloid leukaemia, unspecified
0.024 0.976 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.024 0.976 0.000
C92.7 Other myeloid leukaemia
0.024 0.976 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.024 0.976 0.000
C92.5 Acute myelomonocytic leukaemia
0.024 0.976 0.000
C92.3 Myeloid sarcoma
0.024 0.976 0.000
C92.2 Subacute myeloid leukaemia
0.024 0.976 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.024 0.976 0.000
C91.4 Hairy-cell leukaemia
0.023 0.977 0.000
C92.4 Acute promyelocytic leukaemia
0.022 0.977 0.000
C91.9 Lymphoid leukaemia, unspecified
0.020 0.980 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.020 0.980 0.000
C91.7 Other lymphoid leukaemia
0.020 0.980 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.020 0.980 0.000
C91.5 Adult T-cell leukaemia
0.020 0.980 0.000
C91.3 Prolymphocytic leukaemia
0.020 0.980 0.000
C91.2 Subacute lymphocytic leukaemia
0.020 0.980 0.000
C90.3 Solitary plasmacytoma
0.018 0.982 0.000
C90.1 Plasma cell leukaemia
0.018 0.982 0.000
O02.1 Missed abortion
0.000 0.983 0.017
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.017 0.983 0.000
C85.0 Lymphosarcoma
0.017 0.983 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.016 0.983 0.000
C91.1 Chronic lymphocytic leukaemia
0.014 0.985 0.000
C85.1 B-cell lymphoma, unspecified
0.014 0.986 0.000
C90.0 Multiple myeloma
0.013 0.987 0.000
C91.0 Acute lymphoblastic leukaemia
0.012 0.987 0.000
C90.2 Plasmacytoma, extramedullary
0.013 0.987 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.010 0.990 0.000
O02 Other abnormal products of conception
0.000 0.991 0.009
M23.36 Other meniscus derangements (Other and unspecified lateral meniscus)
0.000 0.991 0.009
C92.0 Acute myeloid leukaemia
0.007 0.992 0.001
I63.9 Cerebral infarction, unspecified
0.007 0.993 0.000
E16.2 Hypoglycaemia, unspecified
0.007 0.993 0.000
O02.9 Abnormal product of conception, unspecified
0.000 0.993 0.007
O02.8 Other specified abnormal products of conception
0.000 0.993 0.007
O00.1 Tubal pregnancy
0.000 0.994 0.006
E87.5 Hyperkalaemia
0.006 0.994 0.000
O00 Ectopic pregnancy
0.000 0.994 0.006
R59.9 Enlarged lymph nodes, unspecified
0.006 0.994 0.000
O00-O08 Pregnancy with abortive outcome
0.000 0.994 0.006
O04.1 Incomplete, complicated by delayed or excessive haemorrhage
0.000 0.995 0.005
O04 Medical abortion
0.000 0.995 0.005
O02.0 Blighted ovum and nonhydatidiform mole
0.000 0.995 0.005
I85.9 Oesophageal varices without bleeding
0.005 0.995 0.000
J38.1 Polyp of vocal cord and larynx
0.000 0.995 0.005
O00.8 Other ectopic pregnancy
0.000 0.995 0.004
O00.2 Ovarian pregnancy
0.000 0.995 0.004
O00.0 Abdominal pregnancy
0.000 0.995 0.004
O07 Failed attempted abortion
0.000 0.995 0.004
O06 Unspecified abortion
0.000 0.995 0.004
O05 Other abortion
0.000 0.995 0.004
O01 Hydatidiform mole
0.000 0.995 0.004
O04.4 Incomplete, without complication
0.000 0.996 0.004
J38.2 Nodules of vocal cords
0.000 0.996 0.004
J38 Diseases of vocal cords and larynx, not elsewhere classified
0.000 0.996 0.004
J38.7 Other diseases of larynx
0.000 0.996 0.004
O08 Complications following abortion and ectopic and molar pregnancy
0.000 0.996 0.004
O00.9 Ectopic pregnancy, unspecified
0.000 0.996 0.004
J38.0 Paralysis of vocal cords and larynx
0.000 0.996 0.004
O04.8 Complete or unspecified, with other and unspecified complications
0.000 0.996 0.004
O04.7 Complete or unspecified, complicated by embolism
0.000 0.996 0.004
O04.6 Complete or unspecified, complicated by delayed or excessive haemorrhage
0.000 0.996 0.004
O04.5 Complete or unspecified, complicated by genital tract and pelvic infection
0.000 0.996 0.004
O04.3 Incomplete, with other and unspecified complications
0.000 0.996 0.004
O04.2 Incomplete, complicated by embolism
0.000 0.996 0.004
O04.0 Incomplete, complicated by genital tract and pelvic infection
0.000 0.996 0.004
J92.0 Pleural plaque with presence of asbestos
0.004 0.996 0.000
E16 Other disorders of pancreatic internal secretion
0.004 0.996 0.000
E78.8 Other disorders of lipoprotein metabolism
0.004 0.996 0.000
J38.4 Oedema of larynx
0.000 0.996 0.004
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)
0.004 0.996 0.000
I22.9 Subsequent myocardial infarction of unspecified site
0.004 0.996 0.000
M79.62 Pain in limb (Upper arm)
0.000 0.996 0.004
O01.9 Hydatidiform mole, unspecified
0.000 0.996 0.003
O01.1 Incomplete and partial hydatidiform mole
0.000 0.996 0.003
O01.0 Classical hydatidiform mole
0.000 0.996 0.003
O05.9 Complete or unspecified, without complication
0.000 0.996 0.003
O05.8 Complete or unspecified, with other and unspecified complications
0.000 0.996 0.003
O05.7 Complete or unspecified, complicated by embolism
0.000 0.996 0.003
O05.6 Complete or unspecified, complicated by delayed or excessive haemorrhage
0.000 0.996 0.003
O05.5 Complete or unspecified, complicated by genital tract and pelvic infection
0.000 0.996 0.003
O05.4 Incomplete, without complication
0.000 0.996 0.003
O05.3 Incomplete, with other and unspecified complications
0.000 0.996 0.003
O05.2 Incomplete, complicated by embolism
0.000 0.996 0.003
O05.1 Incomplete, complicated by delayed or excessive haemorrhage
0.000 0.996 0.003
O05.0 Incomplete, complicated by genital tract and pelvic infection
0.000 0.996 0.003
O06.9 Complete or unspecified, without complication
0.000 0.996 0.003
O06.8 Complete or unspecified, with other and unspecified complications
0.000 0.996 0.003
O06.7 Complete or unspecified, complicated by embolism
0.000 0.996 0.003
O06.6 Complete or unspecified, complicated by delayed or excessive haemorrhage
0.000 0.996 0.003
O06.5 Complete or unspecified, complicated by genital tract and pelvic infection
0.000 0.996 0.003
O06.4 Incomplete, without complication
0.000 0.996 0.003
O06.3 Incomplete, with other and unspecified complications
0.000 0.996 0.003
O06.2 Incomplete, complicated by embolism
0.000 0.996 0.003
O06.1 Incomplete, complicated by delayed or excessive haemorrhage
0.000 0.996 0.003
O06.0 Incomplete, complicated by genital tract and pelvic infection
0.000 0.996 0.003
O07.9 Other and unspecified failed attempted abortion, without complication
0.000 0.996 0.003
O07.8 Other and unspecified failed attempted abortion, with other and unspecified complications
0.000 0.996 0.003
O07.7 Other and unspecified failed attempted abortion, complicated by embolism
0.000 0.996 0.003
O07.6 Other and unspecified failed attempted abortion, complicated by delayed or excessive haemorrhage
0.000 0.996 0.003
O07.5 Other and unspecified failed attempted abortion, complicated by genital tract and pelvic infection
0.000 0.996 0.003
O07.4 Failed medical abortion, without complication
0.000 0.996 0.003
O07.3 Failed medical abortion, with other and unspecified complications
0.000 0.996 0.003
O07.2 Failed medical abortion, complicated by embolism
0.000 0.996 0.003
O07.1 Failed medical abortion, complicated by delayed or excessive haemorrhage
0.000 0.996 0.003
O07.0 Failed medical abortion, complicated by genital tract and pelvic infection
0.000 0.996 0.003
R59 Enlarged lymph nodes
0.004 0.996 0.000
J38.6 Stenosis of larynx
0.000 0.997 0.003
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.003 0.997 0.000
O08.9 Complication following abortion and ectopic and molar pregnancy, unspecified
0.000 0.997 0.003
O08.8 Other complications following abortion and ectopic and molar pregnancy
0.000 0.997 0.003
O08.7 Other venous complications following abortion and ectopic and molar pregnancy
0.000 0.997 0.003
O08.6 Damage to pelvic organs and tissues following abortion and ectopic and molar pregnancy
0.000 0.997 0.003
O08.5 Metabolic disorders following abortion and ectopic and molar pregnancy
0.000 0.997 0.003
O08.4 Renal failure following abortion and ectopic and molar pregnancy
0.000 0.997 0.003
O08.3 Shock following abortion and ectopic and molar pregnancy
0.000 0.997 0.003
O08.2 Embolism following abortion and ectopic and molar pregnancy
0.000 0.997 0.003
O08.0 Genital tract and pelvic infection following abortion and ectopic and molar pregnancy
0.000 0.997 0.003
O03 Spontaneous abortion
0.000 0.997 0.003
R59.1 Generalised enlarged lymph nodes
0.003 0.997 0.000
N94.8 Other specified conditions associated with female genital organs and menstrual cycle
0.003 0.997 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.003 0.997 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.003 0.997 0.000
J38.5 Laryngeal spasm
0.000 0.997 0.003
K73.2 Chronic active hepatitis, not elsewhere classified
0.003 0.997 0.000
W44.0 Home
0.003 0.997 0.000
Y54.4 Loop [high-ceiling] diuretics
0.003 0.997 0.000
Y44.2 Anticoagulants
0.003 0.997 0.000
O08.1 Delayed or excessive haemorrhage following abortion and ectopic and molar pregnancy
0.000 0.997 0.003
E16.9 Disorder of pancreatic internal secretion, unspecified
0.003 0.997 0.000
E16.8 Other specified disorders of pancreatic internal secretion
0.003 0.997 0.000
E16.4 Abnormal secretion of gastrin
0.003 0.997 0.000
E16.3 Increased secretion of glucagon
0.003 0.997 0.000
E16.1 Other hypoglycaemia
0.003 0.997 0.000
I22.1 Subsequent myocardial infarction of inferior wall
0.003 0.997 0.000
M79.65 Pain in limb (Pelvic region and thigh)
0.000 0.997 0.003
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
0.003 0.997 0.000
O03.9 Complete or unspecified, without complication
0.000 0.997 0.003
Y54.5 Other diuretics
0.003 0.997 0.000
Y49.5 Other antipsychotics and neuroleptics
0.003 0.997 0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.997 0.003
E16.0 Drug-induced hypoglycaemia without coma
0.003 0.997 0.000
Y54.3 Benzothiadiazine derivatives
0.003 0.997 0.000
R94.5 Abnormal results of liver function studies
0.000 0.997 0.003
Y44 Agents primarily affecting blood constituents
0.003 0.997 0.000
I63 Cerebral infarction
0.003 0.997 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.003 0.997 0.000
M79.60 Pain in limb (Multiple sites)
0.000 0.997 0.003
R59.0 Localised enlarged lymph nodes
0.003 0.997 0.000
W44 Foreign body entering into or through eye or natural orifice
0.003 0.997 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.003 0.997 0.000
H61.2 Impacted cerumen
0.003 0.997 0.000
Y54.9 Mineral salts, not elsewhere classified
0.003 0.997 0.000
Y54.8 Agents affecting uric acid metabolism
0.003 0.997 0.000
Y54.7 Agents affecting calcification
0.003 0.997 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.003 0.997 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.003 0.997 0.000
Y54.0 Mineralocorticoids
0.003 0.997 0.000
J81 Pulmonary oedema
0.003 0.997 0.000
O03.8 Complete or unspecified, with other and unspecified complications
0.000 0.997 0.003
O03.7 Complete or unspecified, complicated by embolism
0.000 0.997 0.003
O03.6 Complete or unspecified, complicated by delayed or excessive haemorrhage
0.000 0.997 0.003
O03.5 Complete or unspecified, complicated by genital tract and pelvic infection
0.000 0.997 0.003
O03.3 Incomplete, with other and unspecified complications
0.000 0.997 0.003
O03.2 Incomplete, complicated by embolism
0.000 0.997 0.003
O03.0 Incomplete, complicated by genital tract and pelvic infection
0.000 0.997 0.003
L27.0 Generalised skin eruption due to drugs and medicaments
0.000 0.997 0.003
Y52.4 Angiotensin-converting-enzyme inhibitors
0.003 0.997 0.000
S05.0 Injury of conjunctiva and corneal abrasion without mention of foreign body
0.003 0.997 0.000
M46.9 Inflammatory spondylopathy, unspecified
0.003 0.997 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.003 0.997 0.000
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)
0.003 0.997 0.000
I27.9 Pulmonary heart disease, unspecified
0.003 0.997 0.000
I22 Subsequent myocardial infarction
0.003 0.997 0.000
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)
0.002 0.997 0.000
D68.8 Other specified coagulation defects
0.002 0.997 0.000
Y52 Agents primarily affecting the cardiovascular system
0.002 0.997 0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries
0.002 0.997 0.000
M79.6 Pain in limb
0.000 0.997 0.003
S05.1 Contusion of eyeball and orbital tissues
0.002 0.998 0.000
W20-W49 Exposure to inanimate mechanical forces
0.002 0.998 0.000
W23 Caught, crushed, jammed or pinched in or between objects
0.002 0.998 0.000
D68.9 Coagulation defect, unspecified
0.002 0.998 0.000
Y49.2 Other and unspecified antidepressants
0.002 0.998 0.000
S05 Injury of eye and orbit
0.002 0.998 0.000
J38.3 Other diseases of vocal cords
0.000 0.998 0.002
Y46.6 Other and unspecified antiepileptics
0.002 0.998 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.002 0.998 0.000
M79.63 Pain in limb (Forearm)
0.000 0.998 0.002
W23.3 Sports and athletics area
0.002 0.998 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.002 0.998 0.000
M62.89 Other specified disorders of muscle (Site unspecified)
0.002 0.998 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.002 0.998 0.000
Y44.7 Plasma substitutes
0.002 0.998 0.000
Y44.6 Natural blood and blood products
0.002 0.998 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.002 0.998 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.002 0.998 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.002 0.998 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.002 0.998 0.000
D68.5 Primary Thrombophilia
0.002 0.998 0.000
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic
0.002 0.998 0.000
I63.1 Cerebral infarction due to embolism of precerebral arteries
0.002 0.998 0.000
Y49.9 Psychotropic drug, unspecified
0.002 0.998 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.002 0.998 0.000
Y49.7 Psychostimulants with abuse potential
0.002 0.998 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.002 0.998 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.002 0.998 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.002 0.998 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.002 0.998 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.002 0.998 0.000
Y52.1 Calcium-channel blockers
0.002 0.998 0.000
Y57 Other and unspecified drugs and medicaments
0.002 0.998 0.000
X60-X84 Intentional self-harm
0.002 0.998 0.000
Chapter XX External causes of morbidity and mortality
0.002 0.998 0.000
M23.3 Other meniscus derangements
0.000 0.998 0.002
S05.2 Ocular laceration and rupture with prolapse or loss of intraocular tissue
0.002 0.998 0.000
Y44.5 Thrombolytic drugs
0.002 0.998 0.000
S05.9 Injury of eye and orbit, part unspecified
0.002 0.998 0.000
S05.5 Penetrating wound of eyeball with foreign body
0.002 0.998 0.000
W02.9 Unspecified place
0.002 0.998 0.000
W44.9 Unspecified place
0.002 0.998 0.000
W44.5 Trade and service area
0.002 0.998 0.000
W44.8 Other specified place
0.002 0.998 0.000
W44.7 Farm
0.002 0.998 0.000
W44.6 Industrial and construction area
0.002 0.998 0.000
W44.4 Street and highway
0.002 0.998 0.000
W44.3 Sports and athletics area
0.002 0.998 0.000
W44.2 School, other institution and public administrative area
0.002 0.998 0.000
W44.1 Residential institution
0.002 0.998 0.000
Y46.4 Iminostilbenes
0.002 0.998 0.000
Y57.8 Other drugs and medicaments
0.002 0.998 0.000
Y48 Anaesthetics and therapeutic gases
0.002 0.998 0.000
V19 Pedal cyclist injured in other and unspecified transport accidents
0.002 0.998 0.000
M79.64 Pain in limb (Hand)
0.000 0.998 0.002
I63.0 Cerebral infarction due to thrombosis of precerebral arteries
0.002 0.998 0.000
D68 Other coagulation defects
0.002 0.998 0.000
K73 Chronic hepatitis, not elsewhere classified
0.002 0.998 0.000
W21 Striking against or struck by sports equipment
0.002 0.998 0.000
Y59 Other and unspecified vaccines and biological substances
0.002 0.998 0.000
Y58 Bacterial vaccines
0.002 0.998 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.002 0.998 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.002 0.998 0.000
O03.1 Incomplete, complicated by delayed or excessive haemorrhage
0.000 0.998 0.002
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.002 0.998 0.000
Q53.1 Undescended testicle, unilateral
0.002 0.998 0.000
Y46.2 Hydantoin derivatives
0.002 0.998 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.002 0.998 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.002 0.998 0.000
V20-V29 Motorcycle rider injured in transport accident
0.002 0.998 0.000
M23.39 Other meniscus derangements (Unspecified ligament or Unspecified meniscus)
0.000 0.998 0.002
D68.3 Haemorrhagic disorder due to circulating anticoagulants
0.002 0.998 0.000
K73.9 Chronic hepatitis, unspecified
0.002 0.998 0.000
K73.8 Other chronic hepatitis, not elsewhere classified
0.002 0.998 0.000
V17.0 Driver injured in nontraffic accident
0.002 0.998 0.000
V19.8 Pedal cyclist [any] injured in other specified transport accidents
0.002 0.998 0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use
0.002 0.998 0.000
M06.9 Rheumatoid arthritis, unspecified
0.000 0.998 0.002
W23.2 School, other institution and public administrative area
0.002 0.998 0.000
W24 Contact with lifting and transmission devices, not elsewhere classified
0.002 0.998 0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.002 0.998 0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.998 0.002
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)
0.002 0.998 0.000
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)
0.002 0.998 0.000
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)
0.002 0.998 0.000
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)
0.002 0.998 0.000
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)
0.002 0.998 0.000
Y46.8 Antispasticity drugs
0.002 0.998 0.000
Y46.7 Anti-Parkinsonism drugs
0.002 0.998 0.000
Y46.5 Valproic acid
0.002 0.998 0.000
Y46.3 Deoxybarbiturates
0.002 0.998 0.000
Y46.1 Oxazolidinediones
0.002 0.998 0.000
Y46.0 Succinimides
0.002 0.998 0.000
V40-V49 Car occupant injured in transport accident
0.002 0.998 0.000
V10-V19 Pedal cyclist injured in transport accident
0.002 0.998 0.000
W26 Contact with knife, sword or dagger
0.002 0.998 0.000
C15.9 Oesophagus, unspecified
0.002 0.998 0.000
D86.9 Sarcoidosis, unspecified
0.002 0.998 0.000
V19.3 Pedal cyclist [any] injured in an unspecified nontraffic accident
0.002 0.998 0.000
V49.9 Car occupant [any] injured in unspecified traffic accident
0.002 0.998 0.000
Y45.0 Opioids and related analgesics
0.002 0.998 0.000
Y85.0 Sequelae of motor-vehicle accident
0.002 0.998 0.000
X70 Intentional self-harm by hanging, strangulation and suffocation
0.002 0.998 0.000
M23.35 Other meniscus derangements (Posterior horn of lateral meniscus)
0.000 0.998 0.002
X62.9 Unspecified place
0.002 0.998 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.002 0.998 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.002 0.998 0.000
Y52.7 Peripheral vasodilators
0.002 0.998 0.000
W45 Foreign body or object entering through skin
0.002 0.998 0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure
0.002 0.998 0.000
W21.9 Unspecified place
0.002 0.998 0.000
V17 Pedal cyclist injured in collision with fixed or stationary object
0.002 0.998 0.000
V20 Motorcycle rider injured in collision with pedestrian or animal
0.002 0.998 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.002 0.998 0.000
I22.8 Subsequent myocardial infarction of other sites
0.002 0.998 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.002 0.998 0.000
V28 Motorcycle rider injured in noncollision transport accident
0.002 0.998 0.000
Y00-Y09 Assault
0.002 0.998 0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.998 0.002
V48 Car occupant injured in noncollision transport accident
0.002 0.998 0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours
0.002 0.998 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.002 0.998 0.000
W46 Contact with hypodermic needle
0.002 0.998 0.000
W43 Exposure to vibration
0.002 0.998 0.000
W42 Exposure to noise
0.002 0.998 0.000
W41 Exposure to high-pressure jet
0.002 0.998 0.000
W40 Explosion of other materials
0.002 0.998 0.000
W39 Discharge of firework
0.002 0.998 0.000
W38 Explosion and rupture of other specified pressurised devices
0.002 0.998 0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose
0.002 0.998 0.000
W36 Explosion and rupture of gas cylinder
0.002 0.998 0.000
W35 Explosion and rupture of boiler
0.002 0.998 0.000
W34 Discharge from other and unspecified firearms
0.002 0.998 0.000
W33 Rifle, shotgun and larger firearm discharge
0.002 0.998 0.000
W32 Handgun discharge
0.002 0.998 0.000
W31 Contact with other and unspecified machinery
0.002 0.998 0.000
W30 Contact with agricultural machinery
0.002 0.998 0.000
W28 Contact with powered lawn mower
0.002 0.998 0.000
W27 Contact with nonpowered hand tool
0.002 0.998 0.000
Y77 Ophthalmic devices associated with adverse incidents
0.002 0.998 0.000
Y60-Y69 Misadventures to patients during surgical and medical care
0.002 0.998 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.002 0.998 0.000
X00-X09 Exposure to smoke, fire and flames
0.002 0.998 0.000
V20.4 Driver injured in traffic accident
0.002 0.998 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.002 0.998 0.000
V98-V99 Other and unspecified transport accidents
0.002 0.998 0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.998 0.002
W23.9 Unspecified place
0.002 0.998 0.000
W23.8 Other specified place
0.002 0.998 0.000
W23.6 Industrial and construction area
0.002 0.998 0.000
W23.5 Trade and service area
0.002 0.998 0.000
W23.0 Home
0.002 0.998 0.000
W23.7 Farm
0.002 0.998 0.000
W23.1 Residential institution
0.002 0.998 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.002 0.998 0.000
V49 Car occupant injured in other and unspecified transport accidents
0.002 0.998 0.000
V01-V09 Pedestrian injured in transport accident
0.002 0.998 0.000
M24.16 Other articular cartilage disorders (Lower leg)
0.002 0.998 0.000
M79.69 Pain in limb (Site unspecified)
0.000 0.998 0.002
M79.68 Pain in limb (Other)
0.000 0.998 0.002
S05.7 Avulsion of eye
0.002 0.998 0.000
S05.6 Penetrating wound of eyeball without foreign body
0.002 0.998 0.000
S05.4 Penetrating wound of orbit with or without foreign body
0.002 0.998 0.000
X70.2 School, other institution and public administrative area
0.002 0.998 0.000
Y60.4 During endoscopic examination
0.002 0.998 0.000
W49 Exposure to other and unspecified inanimate mechanical forces
0.002 0.998 0.000
W87 Exposure to unspecified electric current
0.002 0.998 0.000
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care
0.002 0.998 0.000
I63.8 Other cerebral infarction
0.002 0.998 0.000
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)
0.000 0.998 0.002
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)
0.002 0.998 0.000
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified
0.002 0.998 0.000
Y45.4 Antirheumatics
0.002 0.998 0.000
Y48.3 Local anaesthetics
0.002 0.998 0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics
0.002 0.998 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.002 0.998 0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.998 0.002
E10.1 With ketoacidosis
0.002 0.998 0.000
V28.2 Unspecified motorcycle rider injured in nontraffic accident
0.002 0.998 0.000
W24.9 Unspecified place
0.002 0.998 0.000
W87.0 Home
0.002 0.998 0.000
Y48.2 Other and unspecified general anaesthetics
0.002 0.998 0.000
Y77.3 Surgical instruments, materials and devices (including sutures)
0.002 0.998 0.000
W20 Struck by thrown, projected or falling object
0.002 0.998 0.000
X65 Intentional self-poisoning by and exposure to alcohol
0.002 0.998 0.000
M62.8 Other specified disorders of muscle
0.002 0.998 0.000
S05.8 Other injuries of eye and orbit
0.002 0.998 0.000
W23.4 Street and highway
0.002 0.998 0.000
Y57.7 Vitamins, not elsewhere classified
0.002 0.998 0.000
Y57.6 Other diagnostic agents
0.002 0.998 0.000
Y57.4 Pharmaceutical excipients
0.002 0.998 0.000
Y57.3 Alcohol deterrents
0.002 0.998 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.002 0.998 0.000
Y57.1 Lipotropic drugs
0.002 0.998 0.000
Y57.0 Appetite depressants [anorectics]
0.002 0.998 0.000
X84 Intentional self-harm by unspecified means
0.002 0.998 0.000
X83 Intentional self-harm by other specified means
0.002 0.998 0.000
X82 Intentional self-harm by crashing of motor vehicle
0.002 0.998 0.000
X81 Intentional self-harm by jumping or lying before moving object
0.002 0.998 0.000
X80 Intentional self-harm by jumping from a high place
0.002 0.998 0.000
X79 Intentional self-harm by blunt object
0.002 0.998 0.000
X77 Intentional self-harm by steam, hot vapours and hot objects
0.002 0.998 0.000
X76 Intentional self-harm by smoke, fire and flames
0.002 0.998 0.000
X75 Intentional self-harm by explosive material
0.002 0.998 0.000
X74 Intentional self-harm by other and unspecified firearm discharge
0.002 0.998 0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge
0.002 0.998 0.000
X72 Intentional self-harm by handgun discharge
0.002 0.998 0.000
X71 Intentional self-harm by drowning and submersion
0.002 0.998 0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
0.002 0.998 0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours
0.002 0.998 0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
0.002 0.998 0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified
0.002 0.998 0.000
Y73 Gastro-enterology and urology devices associated with adverse incidents
0.002 0.998 0.000
Y35-Y36 Legal intervention and operations of war
0.002 0.998 0.000
Y10-Y34 Event of undetermined intent
0.002 0.998 0.000
X85-X99 Assault
0.002 0.998 0.000
X30-X39 Exposure to forces of nature
0.002 0.998 0.000
X10-X19 Contact with heat and hot substances
0.002 0.998 0.000
W75-W84 Other accidental threats to breathing
0.002 0.998 0.000
W65-W74 Accidental drowning and submersion
0.002 0.998 0.000
V95-V97 Air and space transport accidents
0.002 0.998 0.000
V90-V94 Water transport accidents
0.002 0.998 0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident
0.002 0.998 0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident
0.002 0.998 0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident
0.002 0.998 0.000
M23.37 Other meniscus derangements-Capsular lig
0.000 0.998 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.